Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Acadia securities between April 29, 2016 and July 9, 2018
July 24, 2018
· 2 min read